GT-300 (Grit Biotechnology)

N/A

Report date: 2026/04/17 10:36:21

Base Information

Drug NameGT-300 (Grit Biotechnology)

Drug Alias NameGT-300

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaN/A

Originator CompaniesShanghai Grit Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Grit Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A